Abstract
This thesis proposal shows the efficiency of different methods of Myostatin inhibition by using CRISPR/CAS9. With the data cataloged by this thesis, researchers will have a better understanding of what methods are better to achieve their goals. The data was collected by reading multiple scientific articles involving the usage of CRISPR/CAS9 to inhibit the Myostatin protein. The data collected from all the different studies were analyzed in the same categories. The experiment that used CRIPSR/CAS9 on in vitro specimens had a superior Myostatin inhibition overall, therefore presenting higher muscle mass. The method using CRISPR/CAS9 to inhibit the Myostatin in vivo and in vitro depends on what the researcher is trying to accomplish. By reading this thesis researchers can understand that if they choose to use an in vitro treatment the results would be way more severe than using an in vivo application treatment.
Thesis Completion
2020
Semester
Spring
Thesis Chair/Advisor
Ahangari, Raheleh
Degree
Bachelor of Science (B.S.)
College
College of Medicine
Department
Burnett School of Biomedical Sciences
Degree Program
Biomedical Sciences
Language
English
Access Status
Open Access
Release Date
5-1-2020
Recommended Citation
Cardone, Marco, "The Effect of Using CRISPR/Cas9 Treatment to Delete the Myostatin Protein In Vivo and In Vitro" (2020). Honors Undergraduate Theses. 683.
https://stars.library.ucf.edu/honorstheses/683